$JZZI Based on Latest Research, JZZ Technologies, Inc. Announces New Immune Boost and Anti-Inflammatory Products Developed Through Nutrific Inc.
New research from GenBio Inc. working with Nutrific Inc. is focused on the body's signaling process to address inflammatory disorders and its reaction to the Cytokine Storm
West Palm Beach, Florida--(Newsfile Corp. - December 22, 2021) - JZZ Technologies, Inc., (OTC Pink: JZZI) is advancing research being forwarded by its anticipated venture with Nutrific, Inc. and GenBio Inc. in order to provide a breakthrough immune boost and anti-inflammatory product line.
The new research focuses on the body's negative reaction to viruses, such as the SARS-2 virus among others. International research supports that this response is an unnatural reaction that should be treatable through immune boost and anti-inflammatory products.
The Nutrific products aim to specifically address the transduction (signaling) process in inflammatory disorders to mitigate the worst effects of a virus and the body's response to them.
These two areas represent massive markets where a relevant natural treatment could provide significant revenues through a patented treatment. The global immune health supplements market is projected to grow from $20.18 billion in 2021 to $31.50 billion in 2028 at a CAGR of 6.6% from 2021 to 2028 (source: Fortune Business Insights).Alongside the immune health market, the Global Anti-Inflammatory Therapeutics market size is estimated to grow at CAGR of almost 6% with USD 27.53 billion during the forecast period 2021-2024 (source: MarketWatch). These are the two markets that Nutrific expects to enter with its new products.
https://finance.yahoo.com/news/based-latest-r...00498.html
New research from GenBio Inc. working with Nutrific Inc. is focused on the body's signaling process to address inflammatory disorders and its reaction to the Cytokine Storm
West Palm Beach, Florida--(Newsfile Corp. - December 22, 2021) - JZZ Technologies, Inc., (OTC Pink: JZZI) is advancing research being forwarded by its anticipated venture with Nutrific, Inc. and GenBio Inc. in order to provide a breakthrough immune boost and anti-inflammatory product line.
The new research focuses on the body's negative reaction to viruses, such as the SARS-2 virus among others. International research supports that this response is an unnatural reaction that should be treatable through immune boost and anti-inflammatory products.
The Nutrific products aim to specifically address the transduction (signaling) process in inflammatory disorders to mitigate the worst effects of a virus and the body's response to them.
These two areas represent massive markets where a relevant natural treatment could provide significant revenues through a patented treatment. The global immune health supplements market is projected to grow from $20.18 billion in 2021 to $31.50 billion in 2028 at a CAGR of 6.6% from 2021 to 2028 (source: Fortune Business Insights).Alongside the immune health market, the Global Anti-Inflammatory Therapeutics market size is estimated to grow at CAGR of almost 6% with USD 27.53 billion during the forecast period 2021-2024 (source: MarketWatch). These are the two markets that Nutrific expects to enter with its new products.
https://finance.yahoo.com/news/based-latest-r...00498.html
